ALS Gestione

Gestione criteri di controllo 2/4

ALS Il CEO è Malcolm Deane, nominato in Mar2023, e ha un mandato di 1.67 anni. la retribuzione annua totale è A$ 2.88M, composta da 53.7% di stipendio e 46.3% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.008% delle azioni della società, per un valore di € 363.13K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 0.9 anni e 3.5 anni.

Informazioni chiave

Malcolm Deane

Amministratore delegato

AU$2.9m

Compenso totale

Percentuale dello stipendio del CEO	53.7%
Mandato del CEO	1.7yrs
Proprietà del CEO	0.008%
Durata media del management	less than a year
Durata media del Consiglio di amministrazione	3.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Malcolm Deane rispetto agli utili di ALS?
Data	Compenso totale	Stipendio	Guadagni aziendali
Sep 30 2024	n/a	n/a	AU$6m
Jun 30 2024	n/a	n/a	AU$10m
Mar 31 2024	AU$3m	AU$2m	AU$13m
Dec 31 2023	n/a	n/a	AU$138m
Sep 30 2023	n/a	n/a	AU$264m
Jun 30 2023	n/a	n/a	AU$270m
Mar 31 2023	AU$1m	AU$73k	AU$275m

Compensazione vs Mercato: La retribuzione totale di Malcolm ($USD 1.87M ) è inferiore alla media delle aziende di dimensioni simili nel mercato German ($USD 3.51M ).

Compensazione vs guadagni: La retribuzione di Malcolm è aumentata di oltre il 20%, mentre gli utili aziendali sono diminuiti di oltre il 20% nell'ultimo anno.

AMMINISTRATORE DELEGATO

Malcolm Deane (40 yo)

1.7yrs

Mandato

AU$2,880,244

Compensazione

Mr. Malcolm Deane, Master of Laws, Juris Doctor, serves as Chief Executive Officer of ALS Limited since May 8, 2023 and had been its Acting Chief Executive Officer since March 7, 2023 until May 8, 2023 and...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Malcolm Deane	CEO, MD & Director	1.7yrs	AU$2.88m	0.0076% € 363.1k
Stuart Hutton	Chief Financial Officer	less than a year	Nessun dato	Nessun dato
Dayna Field	General Counsel & Company Secretary	less than a year	Nessun dato	Nessun dato
Michael Burcham	Chief Risk Officer	no data	Nessun dato	Nessun dato
Heike Truol	Chief Strategy Officer	less than a year	Nessun dato	Nessun dato
Greg Affleck	Group Financial Controller	no data	Nessun dato	Nessun dato

0.9yrs

Durata media

54yo

Età media

Gestione esperta: Il team dirigenziale di CP4 non è considerato esperto (durata media 0.9 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Malcolm Deane	CEO, MD & Director	1.7yrs	AU$2.88m	0.0076% € 363.1k
John Mulcahy	Independent Non-Executive Director	12.8yrs	AU$207.35k	0.016% € 775.2k
Nigel Garrard	Independent Deputy Chairman	1.4yrs	AU$172.13k	0.0054% € 259.0k
Tonianne Dwyer	Independent Non-Executive Director	8.3yrs	AU$217.35k	0.0056% € 266.2k
Leslie Desjardins	Independent Non-Executive Director	5yrs	AU$225.82k	0.0029% € 138.3k
Erica Mann	Independent Non-Executive Director	less than a year	AU$16.17k	Nessun dato
Peter Possemiers	Independent Non-Executive Director	2yrs	AU$210.69k	0.0027% € 129.8k
Siddhartha Kadia	Independent Non-Executive Director	5.8yrs	AU$222.36k	0.0019% € 92.2k

3.5yrs

Durata media

62.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di CP4 sono considerati esperti (durata media dell'incarico 3.5 anni).

ALS Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

ALS Limited Appoints Dayna Field as General Counsel and Company Secretary, Effective 1 October 2024

ALS Limited Announces Resignation of Michael Pearson as Company Secretary & General Counsel

ALS Limited, Annual General Meeting, Jul 31, 2024

ALS Limited Appoints Stuart Hutton as Chief Financial Officer, Effective 1 February 2024

ALS Limited Announces Stepdown of Luis Damasceno as Chief Financial Officer, Effective 19 January 2024

ALS Limited Appoints Heike Truöl as Chief Strategy Officer

Recent updates

Now 21% overvalued

Now 20% overvalued

ALS Limited Appoints Dayna Field as General Counsel and Company Secretary, Effective 1 October 2024

ALS Limited Announces Resignation of Michael Pearson as Company Secretary & General Counsel

ALS Limited to Report Fiscal Year 2025 Results on May 27, 2025

Final dividend of AU$0.039 announced

New minor risk - Earnings quality

Full year 2024 earnings released: EPS: AU$0.027 (vs AU$0.57 in FY 2023)

ALS Limited (ASX:ALQ) agreed to acquire Wessling Holding Gmbh & Co.Kg.

Now 20% undervalued after recent price drop

Now 20% undervalued

ALS Limited, Annual General Meeting, Jul 31, 2024

ALS Limited Appoints Stuart Hutton as Chief Financial Officer, Effective 1 February 2024

Investor sentiment improves as stock rises 19%

ALS Limited Announces Stepdown of Luis Damasceno as Chief Financial Officer, Effective 19 January 2024

ALS Limited Appoints Heike Truöl as Chief Strategy Officer

ALS Limited to Report Fiscal Year 2024 Results on May 21, 2024

Independent Chairman recently bought €364k worth of stock

ALS Limited Announces Board Changes

Upcoming dividend of AU$0.19 per share at 3.4% yield

ALS Limited Declares Final Dividend for the Fiscal Year 2023, Payable on 6 July 2023

Full year 2023 earnings released: EPS: AU$0.57 (vs AU$0.39 in FY 2022)

ALS Limited Appoints Malcolm Deane as Managing Director

Insufficient new directors

Upcoming dividend of AU$0.20 per share

First half 2023 earnings released: EPS: AU$0.30 (vs AU$0.15 in 1H 2022)

ALS Limited Declares an Unfranked Interim Dividend for the First Half of Fiscal Year 2023, Payable on 16 December 2022

ALS Limited Appoints Peter Possemiers as an Independent Non-Executive Director Effective 1 November 2022

ALS Limited Declares Final Dividend

ALS Limited (ASX:ALQ) announces an Equity Buyback for 9,000,000 shares, representing 1.86% for AUD 100 million.

ALS Limited to Report Fiscal Year 2023 Results on May 24, 2023

ALS Limited (ASX:ALQ) made an non-binding indicative offer to acquire HRL Holdings Limited (ASX:HRL) for AUD 79 million.

ALS Limited (ASX:ALQ) made an non-binding indicative offer to acquire HRL Holdings Limited (ASX:HRL) for AUD 79 million.

Independent Non-Executive Director recently bought €59k worth of stock

Independent Non-Executive Director recently bought €59k worth of stock

Upcoming dividend of AU$0.17 per share

Full year 2022 earnings released: EPS: AU$0.40 (vs AU$0.36 in FY 2021)

ALS Limited Declares Dividend for the Period Ended March 31, 2022, Payable on July 4, 2022

ALS Limited Declares Dividend for the Period Ended March 31, 2022, Payable on July 4, 2022

ALS Limited to Report First Half, 2023 Results on Nov 14, 2022

Insufficient new directors

Investor sentiment improved over the past week

Insufficient new directors

ALS Limited (ASX:ALQ) agreed to acquire MinAnalytical Laboratory Services Pty Ltd. from Perenti Global Limited (ASX:PRN) for AUD 39 million.

Upcoming dividend of AU$0.16 per share

First half 2022 earnings released: EPS AU$0.15 (vs AU$0.14 in 1H 2021)

Independent Non-Executive Director recently bought €73k worth of stock

Investor sentiment improved over the past week

Upcoming dividend of AU$0.15 per share

Full year 2021 earnings released: EPS AU$0.36 (vs AU$0.16 in FY 2020)

ALS Limited Declares Final Dividend, payable on July 5, 2021

ALS Limited (ASX:ALQ) entered in an agreement to acquire Investiga.

New 90-day high: €6.90

New 90-day high: €6.45

ALS Limited to Report Fiscal Year 2021 Final Results on Jun 23, 2021

First half 2021 earnings released: EPS AU$0.15

ALS Limited, Annual General Meeting, Jul 28, 2021

Revenue misses expectations

ALS Limited to Report Fiscal Year 2021 Results on May 26, 2021

New 90-day high: €6.00

New 90-day high: €5.80

New 90-day high: €5.75

New 90-day high - €5.50

New 90-day high - €5.40

New 90-day high - €4.58

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione